Melissa von Goetz
Cerus (United States)(US)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Blood groups and transfusion, COVID-19 Impact on Reproduction, Erythrocyte Function and Pathophysiology
Most-Cited Works
- → Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL(2007)602 cited
- → Functional identification of kinases essential for T-cell activation through a genetic suppression screen(2004)21 cited
- → Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells(2020)14 cited
- → Antibodies against biotin‐labeled red blood cells can shorten posttransfusion survival(2022)11 cited
- → Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment(2022)10 cited
- → Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study(2020)8 cited
- → 556: CONSISTENT FIBRINOGEN YIELD IN PATHOGEN-REDUCED (PR) CRYOPRECIPITATE STORED FOR FIVE DAYS POST-THAW(2017)